Ishibashi R, Inaba Y, Koshizaka M, Takatsuna Y, et al. Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A co Diabetes Obes Metab 2024 Jan 19. doi: 10.1111/dom.15454.
PMID: 38240052